SC
MIST icon

Steven Cohen’s Milestone Pharmaceuticals MIST Stock Holding History

Steven Cohen’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.25M Buy
5,411,138
+4,325,455
+398% +$6.91M 0.01% 1504
2026
Q1 		$1.29M Buy
1,085,683
+603,328
+125% +$1.06M ﹤0.01% 2592
2025
Q4 		$974K Buy
+482,355
New +$1.04M ﹤0.01% 2891
2023
Q3 		– Sell
-232,659
Closed -$663K – 2724
2023
Q2 		$663K Sell
232,659
-1,042,341
-82% -$3.93M ﹤0.01% 1208
2023
Q1 		$5.02M Buy
1,275,000
+400,000
+46% +$1.46M 0.02% 751
2022
Q4 		$3.46M Buy
+875,000
New +$4.61M 0.01% 835

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Steven Cohen's MIST Position: Q2 2026 in Review

Steven Cohen increased its Milestone Pharmaceuticals (MIST) stake by 398% in Q2 2026, buying an estimated $6.91M and bringing the position to 5,411,138 shares worth $7.25M. The position accounts for 0.01% of the portfolio, ranked #1504.

Steven Cohen first reported a position in MIST in Q4 2022 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Steven Cohen held 5,411,138 shares of Milestone Pharmaceuticals worth $7.25M as of Q2 2026.
  • Steven Cohen bought 4,325,455 Milestone Pharmaceuticals shares in Q2 2026, an estimated $6.91M.
  • Milestone Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1504 holding.
  • Steven Cohen first reported a position in Milestone Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.